Detection of micrometastasis in bone marrow of pancreatic cancer patients

Annals of Oncology

Volumn 10, Issue SUPPL. 4, 1999, Pages

  Thorban, Stefan ^a   Roder, J D ^b   Siewert, J R ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b NONE

Author keywords

Cytokeratins; Immunocytochemistry; Micrometastasis; Monoclonal antibodies; Pancreatic carcinoma

Indexed keywords

ALKALINE PHOSPHATASE; CYTOKERATIN; MONOCLONAL ANTIBODY;

BONE MARROW BIOPSY; BONE MARROW METASTASIS; CANCER RECURRENCE; CANCER SURVIVAL; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PRIORITY JOURNAL; PROGNOSIS;

EID: 0032815517     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/10.suppl_4.S111     Document Type: Conference Paper

References (15)

1. Geer RJ, Brennan MF. Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg 1993; 193: 68-73.
2. Hermanek P. Staging of exocrine pancreatic carcinoma. Eur J Surg Oncol 1991; 17: 167-72.
3. Zerbi A, Balzano G, Bottura R et al. Reliability of pancreatic cancer staging classifications. Int J of Pancreatol 1994; 15: 13-18.
4. Gudjonsson B. Cancer of the pancreas. Cancer 1987; 60: 2284-03
5. Höfler H. Prognosefaktoren beim Pancreascarcinom. Chirurg 1994;65:253-57.
6. Roder JD, Siewert JR. Analyse prognoseassoziierter Faktoren beim Pankreaskopf- und periampullärem Carcinom. Chirurg 1992; 63: 410-15.
7. Schlimok G, Funke I, Holtzmann B et al. Micrometastic cancer cells in bone marrow: In vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies. Proc Natl Acad-Sci USA 1987;84:8672-76.
8. Lindemann F, Schlimok G, Dischedl P et al. Prognostic significance of micrometastic tumour cells in bone marrow of colorectal cancer cells. Lancet 1992; 340: 685-89.
9. Pantel K, Itzbicki JR, Angstwurm M et al. Immunocytological detection of bone marrow micrometastasis in operable Non-Small Cell Lung Cancer. Cancer Research 1993; 53: 1027-31.
10. Schlimok G, Funke I, Pantel K et al. Micrometastic tumor cells in bone marrow of patients with gastric cancer: Methodological aspects of detection and prognostic significance. Eur J Cancer 1991; 27: 1461-65.
11. Cordell J, Richardson TC, Pulford KAF et al. Production of monoclonal antibodies against human epithelial membrane antigen for use in diagnostic immunocytochemistry. Br J Cancer 1985; 52: 347-54.
12. Riethmüller G, Schlimok G, Lehmann JM et al. Immunological analysis of micrometastases and the metastatic phenotype of human tumours. In Melchers F et al., eds. Progress in Immunology. 7. Berlin Heidelberg New York, Springer, 1989; 1079-86.
13. Riethmüller G, Johnson JP. Monoclonal antibodies in the detection and therapy of micrometastic cancers. Cur Opin Immunol 1992; 4: 647-55.
14. Gatter KC, Abdulaziz Z, Beverly P et al. Use of monoclonal antibodies for the histopathological diagnosis of human malignancy. J Clin Pathol 1982; 35: 1253-67.
15. Juhl H, Stritzel M, Wroblewski A et al. Immunocytological detection of micrometastic cells: Comparative evaluation of findings in the peritoneal cavity and the bone marrow of gastric, colorectal and pancreatic cancer patients. Int J Cancer 1994; 57: 1-6.